Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594685 · ClinicalTrials.gov registry record
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
A clinical trial, sponsored by Carelon Research.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00594685 is a clinical trial that was terminated before completion, run by Carelon Research. The registered enrollment target is 10 participants.
The verdict
NCT00594685 was terminated before completion, sponsored by Carelon Research.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Heparin-induced thrombocytopenia (HIT), a condition characterized by low platelet levels and possible blood clots, occurs in a small number of people after treatment with the drug heparin. Some people with HIT may show symptoms of a blood clot at the time of HIT diagnosis, but in another form of HIT, known as isolated HIT, people do not show blood clot symptoms even though they might have a blood clot. This study will use ultrasound tests to evaluate the presence of blood clots at the time of an HIT diagnosis and in the following month.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594685
The ClinicalTrials.gov registry entry for NCT00594685 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00594685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594685 about?
NCT00594685 is a clinical study titled "Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)". Heparin-induced thrombocytopenia (HIT), a condition characterized by low platelet levels and possible blood clots, occurs in a small number of people after treatment with the drug heparin. Some people with HIT may show symptoms of a blood clot at the time of HIT diagnosis, but in another form of HIT...
What is the current status of trial NCT00594685?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2008-01. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00594685?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.